journal article·2019-03Open access

Influence of PDLA nanoparticles size on drug release and interaction with cells

Ana Luísa Cartaxo, Ana R. Costa‐Pinto, Albino Martins, Susana Faria, Virgínia M. F. Gonçalves, Maria Elizabeth Tiritan, Helena Ferreira, Nuno M. Neves

Abstract

Abstract Polymeric nanoparticles (NPs) are strong candidates for the development of systemic and targeted drug delivery applications. Their size is a determinant property since it defines the NP–cell interactions, drug loading capacity, and release kinetics. Herein, poly(d,l‐lactic acid) (PDLA) NPs were produced by the nanoprecipitation method, in which the influence of type and concentration of surfactant as well as PDLA concentration were assessed. The adjustment of these parameters allowed the successful production of NPs with defined medium sizes, ranging from 80 to 460 nm. The surface charge of the different NPs populations was consistently negative. Prednisolone was effectively entrapped and released from NPs with statistically different medium sizes (i.e., 80 or 120 nm). Release profiles indicate that these systems were able to deliver appropriate amounts of drug with potential applicability in the treatment of inflammatory conditions. Both NPs populations were cytocompatible with human endothelial and fibroblastic cells, in the range of concentrations tested (0.187–0.784 mg/mL). However, confocal microscopy revealed that within the range of sizes tested in our experiments, NPs presenting a medium size of 120 nm were able to be internalized in endothelial cells. In summary, this study demonstrates the optimization of the processing conditions to obtain PDLA NPs with narrow size ranges, and with promising performance for the treatment of inflammatory diseases. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 482–493, 2019.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

3B's Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine Guimarães Portugal

ICVS/3B's – PT Government Associate Laboratory Braga Portugal

Universidade Católica Portuguesa CBQF – Centro de Biotecnologia e Química Fina – Laboratório Associado, Escola Superior de Biotecnologia 4200‐374 Porto Portugal

Department of Mathematics for Science and Technology Research CMAT, University of Minho 4800‐058 Guimarães Portugal

CESPU Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde Paredes Portugal

Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia Universidade do Porto 4050‐313 Porto Portugal

Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR) Universidade do Porto 4050‐123 Porto Portugal

The Discoveries Centre for Regenerative and Precision Medicine Headquarters at University of Minho Guimarães Portugal

References (63)

Show source-provided references
1. 10.1126/science.109583310.1126/science.1095833 ↗
2. 10.1002/wnan.115710.1002/wnan.1157 ↗
3. 10.3109/02652048.2011.56976310.3109/02652048.2011.569763 ↗
4. 10.1002/term.181710.1002/term.1817 ↗
5. 10.1002/adhm.20130069110.1002/adhm.201300691 ↗
6. 10.1038/nrc90310.1038/nrc903 ↗
7. 10.1016/j.jconrel.2007.09.01310.1016/j.jconrel.2007.09.013 ↗
8. 10.2217/17435889.2.6.78910.2217/17435889.2.6.789 ↗
9. 10.1002/adhm.20130060710.1002/adhm.201300607 ↗
10. 10.1081/DDC-12000148110.1081/DDC-120001481 ↗
11. 10.1016/S0079-6700(00)00024-110.1016/S0079-6700(00)00024-1 ↗
12. 10.1371/journal.pone.011427110.1371/journal.pone.0114271 ↗
13. 10.1016/j.jsps.2017.10.01210.1016/j.jsps.2017.10.012 ↗
14. 10.1023/A:101608510888910.1023/A:1016085108889 ↗
15. Quantum dot: Magic nanoparticle for imaging, detection and targeting
16. Ratner BD · 2014
17. 10.1021/nn102324e10.1021/nn102324e ↗
18. 10.1039/C4TB01071J10.1039/C4TB01071J ↗
19. Polyvalent mesoporous silica nanoparticle‐aptamer bioconjugates target breast cancer cells
20. 10.1016/j.yexmp.2008.12.00410.1016/j.yexmp.2008.12.004 ↗
21. 10.1002/adhm.20120025710.1002/adhm.201200257 ↗
22. 10.1002/term.151910.1002/term.1519 ↗
23. Development of new chitosan/carrageenan nanoparticles for drug delivery applications10.1002/jbm.a.32466 ↗
24. Development of a new drug carrier made from alginate
25. 10.1002/adhm.20120046710.1002/adhm.201200467 ↗
26. 10.2147/DDDT.S3995610.2147/DDDT.S39956 ↗
27. 10.1016/j.progpolymsci.2007.05.01710.1016/j.progpolymsci.2007.05.017 ↗
28. 10.1016/0032-3861(79)90009-010.1016/0032-3861(79)90009-0 ↗
29. 10.3144/expresspolymlett.2015.4210.3144/expresspolymlett.2015.42 ↗
30. 10.3390/polym303137710.3390/polym3031377 ↗
31. 10.1002/jps.2081710.1002/jps.20817 ↗
32. 10.1002/art.2142110.1002/art.21421 ↗
33. 10.1093/rheumatology/keu13510.1093/rheumatology/keu135 ↗
34. 10.1007/s11095-011-0622-310.1007/s11095-011-0622-3 ↗
35. 10.1128/AAC.06049-1110.1128/AAC.06049-11 ↗
36. 10.1088/0957-4484/22/49/49400210.1088/0957-4484/22/49/494002 ↗
37. 10.1021/ja907887z10.1021/ja907887z ↗
38. 10.1016/j.jconrel.2014.06.03810.1016/j.jconrel.2014.06.038 ↗
39. 10.1016/j.ejpb.2004.04.00610.1016/j.ejpb.2004.04.006 ↗
40. 10.1021/bc050137k10.1021/bc050137k ↗
41. 10.1021/mp400677y10.1021/mp400677y ↗
42. 10.1038/sj.bjp.070748710.1038/sj.bjp.0707487 ↗
43. 10.1016/j.ijpharm.2013.07.01710.1016/j.ijpharm.2013.07.017 ↗
44. 10.1073/pnas.110663410810.1073/pnas.1106634108 ↗
45. 10.1016/j.colsurfb.2013.03.02710.1016/j.colsurfb.2013.03.027 ↗
46. 10.1016/j.jcis.2006.07.03110.1016/j.jcis.2006.07.031 ↗
47. 10.1163/156856204175309810.1163/1568562041753098 ↗
48. 10.1007/BFb004306210.1007/BFb0043062 ↗
49. 10.1016/j.addr.2006.09.01710.1016/j.addr.2006.09.017 ↗
50. 10.1023/A:101898122209210.1023/A:1018981222092 ↗
51. 10.3109/08982104.2015.110833310.3109/08982104.2015.1108333 ↗
52. 10.1111/j.1365-2125.1977.tb00723.x10.1111/j.1365-2125.1977.tb00723.x ↗
53. Red cell and plasma volumes in normal adults
54. 10.1186/1471-2164-11-35910.1186/1471-2164-11-359 ↗
55. 10.1016/S0168-3659(00)00358-810.1016/S0168-3659(00)00358-8 ↗
56. 10.1021/nn201624c10.1021/nn201624c ↗
57. 10.1007/s11095-012-0958-310.1007/s11095-012-0958-3 ↗
58. 10.1016/j.biomaterials.2004.07.05010.1016/j.biomaterials.2004.07.050 ↗
59. Endocytosis and exocytosis of nanoparticles in mammalian cells
60. 10.1021/nn800532m10.1021/nn800532m ↗
61. 10.4199/C00025ED1V01Y201101ISP01310.4199/C00025ED1V01Y201101ISP013 ↗
62. 10.4155/tde.12.14010.4155/tde.12.140 ↗
63. 10.1146/annurev-physiol-021909-13583310.1146/annurev-physiol-021909-135833 ↗